The Enterra™ Therapy system uses an implanted neurostimulator to generate mild electrical pulses through insulated wires (leads) to the lower stomach.
Enterra™ Therapy may help to control symptoms of chronic nausea and vomiting associated with gastroparesis caused by diabetes or unknown origin in patients aged 18-70 years.
Humanitarian Device: The Enterra™ Therapy system for gastric electrical stimulation is authorized by Federal law for use in treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology. The effectiveness of this device for this use has not been demonstrated. What does this mean?
Enterra is now a part of Enterra Medical!
Enterra Medical is a medical device company dedicated to a singular focus: helping more people with chronic gastroparesis live better lives by advancing technology, expanding clinical science, and accelerating access to the Enterra Therapy. In order to increase investment and focus on the therapy, Enterra Medical was formed in 2022 and has begun the process to assume ongoing responsibility of Enterra Therapy from Medtronic. Medtronic remains a strong operational partner in this new management model.
To learn more about Enterra, find a physician, or to view product manuals and safety information please visit Enterra Medical.